INNOCARE(09969),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

09969 INNOCARE

Closed 06-05 16:09:12

10.550

-0.210

-1.95%

High10.980	Low10.470	Vol5.79M
Open10.830	D1 Closing10.760	Amplitude4.74%
Mkt Cap18.59B	Tradable Cap15.76B	Total Shares1.76B
T/O61.72M	T/O Rate0.39%	Tradable Shares1.49B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"09969","market":"HK","secType":"STK","nameCN":"INNOCARE","latestPrice":10.55,"timestamp":1780646952008,"preClose":10.76,"halted":0,"volume":5794270,"delay":0,"changeRate":-0.01951672862453523,"floatShares":1494000000,"shares":1762000000,"eps":0.38,"marketStatus":"Closed","change":-0.21,"latestTime":"06-05 16:09:12","open":10.83,"high":10.98,"low":10.47,"amount":61716545,"amplitude":0.047398,"askPrice":10.55,"askSize":4000,"bidPrice":10.53,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":0.469,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1780882200000},"marketStatusCode":5,"adr":0,"listingDate":1584892800000,"exchange":"SEHK","adjPreClose":10.76,"openAndCloseTimeList":[[1780623000000,1780632000000],[1780635600000,1780646400000]],"volumeRatio":0.613115,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688428","market":"SH","secType":"STK","nameCN":"Innocare Pharma Limited","latestPrice":21.44,"timestamp":1780642800000,"preClose":21.8,"halted":0,"volume":6992600,"delay":0,"premium":"-57.44"}},"requestUrl":"/m/hq/s/09969","defaultTab":"news","newsList":[{"id":"2640977761","title":"A Look At InnoCare Pharma (SEHK:9969) Valuation After Recent Share Price Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=2640977761","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640977761?lang=en_us&edition=fundamental","pubTime":"2026-06-03 14:16","pubTimestamp":1780467404,"startTime":"0","endTime":"0","summary":"Recent performance and context\nInnoCare Pharma (SEHK:9969) has drawn attention after its share price closed at HK$11.26, with the stock down 2.3% over the past day and 3.7% over the past week.\nThat shorter term weakness sits alongside a decline of 18.6% over the past month and a year to date fall of 9.9%. Over a longer period, the stock is up 2.9% over the past 3 months and 2.0% over the past year.\nSee our latest analysis for InnoCare Pharma.\nRecent trading has been choppy, with the share...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/a-look-at-innocare-pharma-sehk9969-valuation-after-recent-sh-3","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/a-look-at-innocare-pharma-sehk9969-valuation-after-recent-sh-3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["09969","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639490386","title":"InnoCare Pharma Gets Acceptance for ITP New Drug Application; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2639490386","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639490386?lang=en_us&edition=fundamental","pubTime":"2026-05-29 13:38","pubTimestamp":1780033123,"startTime":"0","endTime":"0","summary":"InnoCare Pharma (SHA:688428, HKG:9969) said China's drug regulator accepted the new drug application for orelabrutinib for treating primary immune thrombocytopenia (ITP), according to a Friday filing with the Shanghai bourse.Shares of the drugmaker rose 3% in recent trade on the Hong Kong bourse.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4199","BK1161","BK1574","09969","BK0239","ITP","688428"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136555407","title":"Innocare's New Drug Application for Orelabrutinib in ITP Accepted for Review by NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=1136555407","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136555407?lang=en_us&edition=fundamental","pubTime":"2026-05-28 16:29","pubTimestamp":1779956955,"startTime":"0","endTime":"0","summary":"Innocare Pharma Limited (688428.SH) announced that the New Drug Application (NDA) for its self-developed Bruton's tyrosine kinase (BTK) inhibitor, orelabrutinib, intended for the treatment of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK0239","BK1161","09969","688428","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638465679","title":"InnoCare Pharma Wins Australia Approval for Lymphoma Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2638465679","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638465679?lang=en_us&edition=fundamental","pubTime":"2026-05-28 11:09","pubTimestamp":1779937762,"startTime":"0","endTime":"0","summary":"InnoCare Pharma  said Australia's Therapeutic Goods Administration approved orelabrutinib for the treatment of adult patients with relapsed or refractory mantle cell lymphoma, according to a Wednesday Hong Kong bourse filing.Shares of the pharmaceutical company fell by over 2% in late-morning trade on Thursday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GEAR.AU","QFN.AU","QRE.AU","GIVE.AU","VAS.AU","SLF.AU","BEAR.AU","OZR.AU","IOZ.AU","IMLC.AU","IIGF.AU","OZF.AU","XAO.AU","BK1161","XJO.AU","XKO.AU","STW.AU","ZYAU.AU","EIGA.AU","E200.AU","DACE.AU","VAP.AU","IISV.AU","BK1574","BBOZ.AU","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100302568","title":"Innocare Pharma's Orelabrutinib Receives Marketing Authorization from Australian TGA","url":"https://stock-news.laohu8.com/highlight/detail?id=1100302568","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100302568?lang=en_us&edition=fundamental","pubTime":"2026-05-27 16:32","pubTimestamp":1779870754,"startTime":"0","endTime":"0","summary":"Innocare Pharma Limited (688428.SH) announced that it has received notification that orelabrutinib (marketed as Yinuokai® and HIBRUKA®) has been granted marketing authorization by the Australian...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","IPOS","BK0239","09969","688428"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638251691","title":"InnoCare Pharma to Vest Over 2.4 Million Shares for 74 Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2638251691","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638251691?lang=en_us&edition=fundamental","pubTime":"2026-05-26 18:59","pubTimestamp":1779793189,"startTime":"0","endTime":"0","summary":"InnoCare Pharma (SHA:688428, HKG:9969) approved the vesting of shares under a stock incentive plan and the cancellation of granted but unvested shares, according to a Tuesday filing with the Shanghai ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1574","BK0239","688428","09969","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186054640","title":"Innocare Shares Surge Over 4% in Afternoon Trading Following Milestone in Novel Anti-Inflammatory Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1186054640","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186054640?lang=en_us&edition=fundamental","pubTime":"2026-05-21 14:08","pubTimestamp":1779343714,"startTime":"0","endTime":"0","summary":"Innocare (09969) saw its shares rise more than 4% in afternoon trading. At the time of writing, the stock was up 3.27% to HKD 12.32, with a turnover of approximately HKD 90.33 million. The increase...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","09969","06978","BK0239","688428","BK1161","VXUS","BK1574","159992","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635678612","title":"InnoCare Pharma Unit Doses First Patient in Autoimmune Disease Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2635678612","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635678612?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:06","pubTimestamp":1778670400,"startTime":"0","endTime":"0","summary":"InnoCare Pharma Ltd.  unit InnoCare Pharma Inc. dosed the first subject in a phase 1 trial of ICP-054 in China.Preclinical data shows the potential of ICP-054 to be a differentiated oral therapy for autoimmune and inflammatory diseases associated with dysregulated IL-17 signaling, according to a Wednesday Hong Kong bourse filing.The Hong Kong-listed drugmaker is developing the drug in partnership with Zenas BioPharma.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["09969","688428","BK0239","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149280129","title":"InnoCare and Zenas BioPharma Dose First Subject in Phase 1 Study of Oral IL-17AA/AF Inhibitor ICP-054","url":"https://stock-news.laohu8.com/highlight/detail?id=1149280129","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149280129?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:03","pubTimestamp":1778670215,"startTime":"0","endTime":"0","summary":"InnoCare Pharma Limited (InnoCare) announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial evaluating ICP-054 (ZB021), a novel oral IL-17AA/AF inhibitor being...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185848254","title":"Innocare Announces First Patient Dosed in Phase 1 Trial for Oral IL-17 Inhibitor ICP-054 (ZB021)","url":"https://stock-news.laohu8.com/highlight/detail?id=1185848254","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185848254?lang=en_us&edition=fundamental","pubTime":"2026-05-13 18:50","pubTimestamp":1778669439,"startTime":"0","endTime":"0","summary":"Innocare (09969) announced that the first participant has been dosed in the Phase 1 clinical trial for ICP-054 (ZB021), a novel oral, potential best-in-class IL-17AA/AF inhibitor. ICP-054 is a new,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK1161","09969","BK1574","688428"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634640513","title":"A Look At InnoCare Pharma (SEHK:9969) Valuation After Recent Share Price Pullback","url":"https://stock-news.laohu8.com/highlight/detail?id=2634640513","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634640513?lang=en_us&edition=fundamental","pubTime":"2026-05-11 13:31","pubTimestamp":1778477471,"startTime":"0","endTime":"0","summary":"Recent performance snapshot\nInnoCare Pharma (SEHK:9969) has drawn investor attention after its shares closed at HK$13.51. The stock was down 3% over the past day and 11% over the past month, but up over the past 3 months.\nSee our latest analysis for InnoCare Pharma.\nThat recent pullback fits into a mixed picture, with the share price up 8.08% year to date and the 1-year total shareholder return at 40%, while the 5-year total shareholder return has been weaker.\nIf you are weighing what else...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/a-look-at-innocare-pharma-sehk9969-valuation-after-recent-sh-2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/a-look-at-innocare-pharma-sehk9969-valuation-after-recent-sh-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","09969","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633017353","title":"Is It Time To Reassess InnoCare Pharma (SEHK:9969) After Its Strong One-Year Share Price Gain?","url":"https://stock-news.laohu8.com/highlight/detail?id=2633017353","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633017353?lang=en_us&edition=fundamental","pubTime":"2026-05-08 01:54","pubTimestamp":1778176475,"startTime":"0","endTime":"0","summary":"If you are wondering whether InnoCare Pharma's current share price really reflects its potential, the starting point is understanding how the stock stacks up on value.\nThe share price closed at HK$13.93 with returns of 0.7% over 7 days, a 10.2% decline over 30 days, an 11.4% gain year to date, and a 44.5% gain over 1 year. This gives useful context before comparing this to longer term figures like the 46.9% 3 year return and the 34.4% 5 year decline.\nRecent company developments and market...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/is-it-time-to-reassess-innocare-pharma-sehk9969-after-its-st","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/is-it-time-to-reassess-innocare-pharma-sehk9969-after-its-st","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["09969","BK1161","BK1574","DCF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166105738","title":"InnoCare Pharma Maintains Stable Share Capital in April; 14.04 Million Shares Remain under Incentive Schemes","url":"https://stock-news.laohu8.com/highlight/detail?id=1166105738","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166105738?lang=en_us&edition=fundamental","pubTime":"2026-05-07 16:44","pubTimestamp":1778143441,"startTime":"0","endTime":"0","summary":"InnoCare Pharma Limited reported no changes to its share capital structure for April 2026, according to the company’s Monthly Return submitted to Hong Kong Exchanges and Clearing Limited on 7 May...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116977360","title":"INNOCARE Shares Rise Nearly 3% on ASCO 2026 Oral Presentation Selection for Mesutoclax Study","url":"https://stock-news.laohu8.com/highlight/detail?id=1116977360","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116977360?lang=en_us&edition=fundamental","pubTime":"2026-04-28 09:56","pubTimestamp":1777341385,"startTime":"0","endTime":"0","summary":"INNOCARE (09969) saw its shares increase by nearly 3%. At the time of writing, the stock was up 2.67%, trading at HK$14.24 with a turnover of HK$29.20 million. The movement follows an announcement...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688428","BK0239","BK4588","VXUS","BK1574","BK4585","BK1161","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630664033","title":"A Look At InnoCare Pharma (SEHK:9969) Valuation After Recent Share Price Momentum And Analyst Discount","url":"https://stock-news.laohu8.com/highlight/detail?id=2630664033","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630664033?lang=en_us&edition=fundamental","pubTime":"2026-04-27 13:07","pubTimestamp":1777266466,"startTime":"0","endTime":"0","summary":"What recent performance says about InnoCare Pharma\nInnoCare Pharma (SEHK:9969) has caught investor attention after a 4.4% move in the latest session, alongside a mixed pattern over the past week, month and past 3 months that highlights shifting sentiment toward the stock.\nOver the past week the share price shows a 6.5% decline, while the past month return sits at 12.1% and the past 3 months at 26.4%. Year to date the stock is up 17.6%, with a 1 year total return of 44.97% and a 3 year total...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/a-look-at-innocare-pharma-sehk9969-valuation-after-recent-sh-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/a-look-at-innocare-pharma-sehk9969-valuation-after-recent-sh-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","09969","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630291385","title":"InnoCare Pharma Limited Just Missed Revenue By 19%: Here's What Analysts Think Will Happen Next","url":"https://stock-news.laohu8.com/highlight/detail?id=2630291385","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630291385?lang=en_us&edition=fundamental","pubTime":"2026-04-26 08:50","pubTimestamp":1777164630,"startTime":"0","endTime":"0","summary":"Last week, you might have seen that InnoCare Pharma Limited ( HKG:9969 ) released its first-quarter result to the...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/innocare-pharma-limited-just-missed-revenue-by-19-heres-what","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/innocare-pharma-limited-just-missed-revenue-by-19-heres-what","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","BK1574","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167024959","title":"INNOCARE Calls 16 June AGM to Vote on 2026 Share Incentive Scheme, RSU Grants and Governance Amendments","url":"https://stock-news.laohu8.com/highlight/detail?id=1167024959","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167024959?lang=en_us&edition=fundamental","pubTime":"2026-04-24 22:43","pubTimestamp":1777041829,"startTime":"0","endTime":"0","summary":"INNOCARE will hold its annual general meeting on 16 June 2026 in Beijing. Shareholders will review the 2025 Annual Report, which recorded operating revenue of RMB 2.37 billion and the first full-year...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199481869","title":"Innocare Awards 15.39 Million Restricted Share Units","url":"https://stock-news.laohu8.com/highlight/detail?id=1199481869","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199481869?lang=en_us&edition=fundamental","pubTime":"2026-04-24 21:27","pubTimestamp":1777037253,"startTime":"0","endTime":"0","summary":"Innocare (09969) announced that on April 24, 2026, the company granted 15.3892 million restricted share units under the 2023 Equity Incentive Plan to three grantees. These units represent...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969","BK1161","BK0239","BK1574","688428"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198970011","title":"InnoCare issues 15.39 million RSUs; executive portion subject to AGM vote","url":"https://stock-news.laohu8.com/highlight/detail?id=1198970011","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198970011?lang=en_us&edition=fundamental","pubTime":"2026-04-24 21:24","pubTimestamp":1777037060,"startTime":"0","endTime":"0","summary":"InnoCare Pharma Limited announced that on 24 April 2026 the board approved a grant of 15.39 million restricted share units (RSUs), equal to about 0.87 % of issued shares (excluding treasury stock),...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176300554","title":"Stock Track | INNOCARE Soars 5.11% Intraday on Stellar Q1 2026 Results with 489% Net Profit Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1176300554","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176300554?lang=en_us&edition=fundamental","pubTime":"2026-04-24 10:35","pubTimestamp":1776998137,"startTime":"0","endTime":"0","summary":"INNOCARE's stock price surged 5.11% during intraday trading on Friday, reflecting strong investor sentiment following the release of the company's latest financial performance.The significant price...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"https://cn.innocarepharma.com","stockEarnings":[{"period":"1week","weight":-0.041},{"period":"1month","weight":-0.2117},{"period":"3month","weight":-0.0904},{"period":"6month","weight":-0.2507},{"period":"1year","weight":-0.0835},{"period":"ytd","weight":-0.1252}],"compareEarnings":[{"period":"1week","weight":0.0099},{"period":"1month","weight":-0.0249},{"period":"3month","weight":-0.0196},{"period":"6month","weight":-0.0319},{"period":"1year","weight":0.0676},{"period":"ytd","weight":-0.0147}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"InnoCare Pharma Ltd is a China-based company mainly engaged in the research and development, production and commercialization of biopharmaceuticals. The Company focuses on areas with unmet clinical needs, such as oncology and autoimmune diseases. The Company's primary product pipeline includes Orelabrutinib, Tafasitamab, ICP-490, ICP-B02, ICP-248, ICP-B05, ICP-332, ICP-488, ICP-192, ICP-723, ICP-033 and ICP-189, and others. Its products are mainly used to treat hematological tumors, solid tumors and autoimmune diseases. The Company is also developing products for the treatment of autoimmune diseases caused by abnormal T cell function. The Company conducts its businesses in domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.103999},{"month":2,"riseRate":0.666667,"avgChangeRate":0.128923},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.010195},{"month":4,"riseRate":0.714286,"avgChangeRate":0.102464},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.059233},{"month":6,"riseRate":0.714286,"avgChangeRate":0.100219},{"month":7,"riseRate":0.5,"avgChangeRate":0.039258},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.082108},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.024907},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.033299},{"month":11,"riseRate":0.833333,"avgChangeRate":0.100833},{"month":12,"riseRate":0.5,"avgChangeRate":-0.012645}],"exchange":"SEHK","name":"INNOCARE","nameEN":"INNOCARE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"INNOCARE(09969),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest INNOCARE(09969) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"INNOCARE,09969,INNOCARE股票,INNOCARE股票老虎,INNOCARE股票老虎国际,INNOCARE行情,INNOCARE股票行情,INNOCARE股价,INNOCARE股市,INNOCARE股票价格,INNOCARE股票交易,INNOCARE股票购买,INNOCARE股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"INNOCARE(09969),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest INNOCARE(09969) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}